Literature DB >> 22826950

[Effect of Jumonji domain-containing protein-3 on the proliferation and migration of lung cancer cell line].

Cuijie Tian1, Hongyu Deng, Xiaoju Tang, Hefang Hu, Xiaojing Liu, Fengming Luo.   

Abstract

For investigating the effect of Jumonji domain-containing protein-3 (JMJD3) on the behavior of lung cancer cell line, A549 proliferation was measured with EDU staining and flow cytometer after JMJD3 expression plasmid and pcDNA3. 1 transfection at 48h. The migration ability of A549 was tested at the same time. The expression of p21 mRNA was measured with RT-PCR. The results showed that JMJD3 transfection increased the EDU positive cells ratio (JMJD3: 40.75% +/- 2.07%, control: 20.97% +/- 1.5%, P < 0.001). G1 phase cell ration also increased after JMJD3 transfection (JMJD3:47. 80% +/- 1.85%, control: 54.60% +/- 0.95%, P = 0.005). The mRNA expression of p21 decreased in JMJD3 group (JMJD3: 35. 89% +/- 3.71%, control: 91.78% +/- 3.74%, P < 0.001). The distances of migration were (0.47 +/- 0.27) cm and (0.96 +/- 0.40) cm after 24h and 48h with JMJD3 tranfection, compared to (0.57 +/- 0.22)cm and (1.08 +/- 0.33)cm in control, respectively (P > 0.05). JMJD3 promoted the proliferation of A549 and decreased the G1 cell numbers, decreased the p21 mRNA, but had no effect on A549 migration.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22826950

Source DB:  PubMed          Journal:  Sheng Wu Yi Xue Gong Cheng Xue Za Zhi        ISSN: 1001-5515


  4 in total

Review 1.  JMJD3 as an epigenetic regulator in development and disease.

Authors:  Jana S Burchfield; Qingtian Li; Helen Y Wang; Rong-Fu Wang
Journal:  Int J Biochem Cell Biol       Date:  2015-07-17       Impact factor: 5.085

2.  JMJD3 suppresses tumor progression in oral tongue squamous cell carcinoma patients receiving surgical resection.

Authors:  Yen-Hao Chen; Chang-Han Chen; Chih-Yen Chien; Yan-Ye Su; Sheng-Dean Luo; Shau-Hsuan Li
Journal:  PeerJ       Date:  2022-07-13       Impact factor: 3.061

3.  A new metabolic gene signature in prostate cancer regulated by JMJD3 and EZH2.

Authors:  Marine Daures; Mouhamed Idrissou; Gaëlle Judes; Khaldoun Rifaï; Frédérique Penault-Llorca; Yves-Jean Bignon; Laurent Guy; Dominique Bernard-Gallon
Journal:  Oncotarget       Date:  2018-05-04

Review 4.  The Functions of the Demethylase JMJD3 in Cancer.

Authors:  Anna Sanchez; Fatma Zohra Houfaf Khoufaf; Mouhamed Idrissou; Frédérique Penault-Llorca; Yves-Jean Bignon; Laurent Guy; Dominique Bernard-Gallon
Journal:  Int J Mol Sci       Date:  2021-01-19       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.